期刊文献+

免疫抑制剂在消化系统疾病中的应用

Application of immunosuppressants used for diseases of digestive system
下载PDF
导出
摘要 消化系统是人体最大的免疫器官,许多消化系统疾病的发病机制与人体的自身免疫密切相关,如炎症性肠病(inflammatory bowel disease,IBD)、自身免疫性肝炎(autoimmune hepatitis,AIH)、原发性胆汁性肝硬化(primary biliary cinhosis,PBC)、原发性硬化性胆管炎(primary sclerosing cholangitis,PSC)等.不同免疫抑制剂在这些疾病治疗中的地位有的业已确定,有的只取得了试验性治疗的成功,而有的尚需大量临床观察研究.
作者 李宁 郝建宇
出处 《临床药物治疗杂志》 2005年第1期29-33,共5页 Clinical Medication Journal
  • 相关文献

参考文献15

  • 1[1]Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology, 1998, 115:813~821
  • 2[2]Corominas H, Domenech M, Gonzalez D, Diaz c, Roca M,Garcia-Gonzalez MA, Pena S, Baiget M. Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy controls. Am J Gastroenterol, 2000,95:2313~2317
  • 3[3]Bousvaros A, Kirschner BS, Werlin SL, Parker Hartihan L,Daum F, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr, 2000, 137: 794~799
  • 4[4]Fellermann K, Ludwig D, Stahl M, David-Walek T, et al.Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Am J Gastroenterol, 1998, 93:1860~1866
  • 5[5]Medina-J, Garcia Buey-L, Moreno-Otero R. Immunopathogenetic and therapeutic aspects of autoimmune hepatitis. Aliment PharmacolTher, 2003 Jan, 17 (1): 1~16
  • 6[6]Abdo-A-A, Bain -V-G, Kichian-K, Lee-S-S. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome. Hepatology, 2002 Dec, 36 (6): 1393~1399
  • 7[7]Heneghan -M-A, McFarlane -I-G. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology, 2002Jan, 35 (1): 7~13
  • 8韩玉坤,陈菊梅.自身免疫性肝炎临床研究现状[J].中华肝脏病杂志,2004,12(3):180-181. 被引量:13
  • 9[9]Mitchison HC, Palmer JM, et al. A controlled trial of prednisolone treatment in primary biliary cirrhosis. J Hepatol, 1992,15: 336~344
  • 10[10]Kaplan MM, Alling DW, et al. A controlled trial of colchicines for primary biliary cirrhosis. N Eng1 J Med, 1986, 91: 1327~1334

二级参考文献7

  • 1韩玉坤,张文瑾,陈菊梅,周华,王林杰.自身免疫性肝病临床与病理研究[J].中华肝脏病杂志,2001,9(S1):82-84. 被引量:11
  • 2Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges,Gastroenterology, 2001, 120:1502-1517.
  • 3Durazzo M, Premoli A, Fagoonee S, et al. Overlap syndromes of autoimmune hepatitis: what is known so far. Dig Dis Sci, 2003, 48:423-430.
  • 4Albert J, Czaja MD. The variant forms of autoimmune hepatitis.Ann Intern Med, 1996, 125: 588-598.
  • 5Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol, 2000, 32(suppl 1): 181-197.
  • 6Burak KW, Urbanski SJ, Swain MG. Successful treatment of refractory Type 1 autoimmune hepatitis with methotrexate. J Hepatol,1998, 29: 990-993.
  • 7赵景民,王松山,孙艳玲,周光德,刘平,孟二红,辛绍杰,张泰和,王福生,毛远丽,李莉,李迎新,张鸿飞,张玲霞,陈菊梅.自身免疫性肝炎临床病理特征及发病机理的研究[J].中华实验和临床病毒学杂志,2002,16(1):27-30. 被引量:14

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部